ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 256 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $723,666 | -12.8% | 25,303 | -22.6% | 0.07% | -33.0% |
| Q1 2023 | $830,123 | +176.7% | 32,682 | +369.2% | 0.10% | +41.1% |
| Q3 2020 | $300,000 | -8.0% | 6,966 | -38.5% | 0.07% | +4.3% |
| Q1 2020 | $326,000 | +6.2% | 11,334 | +134.5% | 0.07% | +34.6% |
| Q4 2019 | $307,000 | – | 4,834 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $206,837,000 | 74.59% |
| ACUTA CAPITAL PARTNERS, LLC | 442,500 | $28,068,000 | 6.95% |
| Vanguard Capital Wealth Advisors | 19,884 | $1,261,000 | 1.32% |
| Matarin Capital Management, LLC | 193,171 | $12,253,000 | 1.17% |
| Ikarian Capital, LLC | 100,000 | $6,343,000 | 1.03% |
| Ikarian Capital, LLC | 100,000 | $6,343,000 | 1.03% |
| HRT FINANCIAL LP | 299,297 | $18,984,000 | 0.82% |
| EAM Investors, LLC | 50,411 | $3,198,000 | 0.70% |
| OAK RIDGE INVESTMENTS LLC | 147,293 | $9,343,000 | 0.69% |
| FIRST MANHATTAN CO. LLC. | 2,068,020 | $131,174,000 | 0.66% |